IP Library › Patent Application 17288077
Patent Application
App. No. 17/288,077

5-AZAINDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/288,077
Abstract

The present invention relates to novel 5-azaindazole derivatives of formula (I), as described and defined herein, and pharmaceutically acceptable salts, solvates and prodrug thereof, as well as pharmaceutical compositions comprising such compounds. The 5-azaindazole derivatives according to the invention have been found to be highly effective dual A 2A /A 2B adenosine receptor antagonists, and can thus be used as therapeutic agents, particularly in the treatment or prevention of hyperproliferative or infectious diseases or disorders.

Claims (959)

1 . A compound of formula (I)

wherein:

R 1A and R 1B are mutually linked to form, together with the nitrogen atom that they are attached to, a heterocycloalkyl which is optionally substituted with one or more groups R 11 ;

or, alternatively, R 1A and R 1B are each independently selected from hydrogen, C 1-5 alkyl, C 2-5 alkenyl, C 2-5 alkynyl, —CO(C 1-5 alkyl), carbocyclyl, and heterocyclyl, wherein said alkyl, said alkenyl, said alkynyl, and the alkyl moiety of said —CO(C 1-5 alkyl) are each optionally substituted with one or more groups R 12 , and further wherein said carbocyclyl and said heterocyclyl are each optionally substituted with one or more groups R 13 ;

each R 11 is independently selected from C 1-5 alkyl, C 2-5 alkenyl, C 2-5 alkynyl, —(C 0-3 alkylene)-OH, —(C 0-3 alkylene)-O(C 1-5 alkyl), —(C 0-3 alkylene)-O(C 1-5 alkylene)-OH, —(C 0-3 alkylene)-O(C 1-5 alkylene)-O(C 1-5 alkyl), —(C 0-3 alkylene)-SH, —(C 0-3 alkylene)-S(C 1-5 alkyl), —(C 0-3 alkylene)-NH 2 , —(C 0-3 alkylene)-NH(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-halogen, —(C 0-3 alkylene)-(C 1-5 haloalkyl), —(C 0-3 alkylene)-O—(C 1-5 haloalkyl), —(C 0-3 alkylene)-CF 3 , —(C 0-3 alkylene)-CN, —(C 0-3 alkylene)-NO 2 , —(C 0-3 alkylene)-CHO, —(C 0-3 alkylene)-CO—(C 1-5 alkyl), —(C 0-3 alkylene)-COOH, —(C 0-3 alkylene)-CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—(C 1-5 alkyl), —(C 0-3 alkylene)-CO—NH 2 , —(C 0-3 alkylene)-CO—NH(C 1-5 alkyl), —(C 0-3 alkylene)-CO—N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-NH—CO—(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-CO—(C 1-5 alkyl), —(C 0-3 alkylene)-NH—CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—NH—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—N(C 1-5 alkyl)-(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —NH 2 , —(C 0-3 alkylene)-SO 2 —NH(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-NH—SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-SO—(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-carbocyclyl, and —(C 0-3 alkylene)-heterocyclyl, wherein the carbocyclyl moiety of said —(C 0-3 alkylene)-carbocyclyl and the heterocyclyl moiety of said —(C 0-3 alkylene)-heterocyclyl are each optionally substituted with one or more groups independently selected from C 1-5 alkyl, C 2-5 alkenyl, C 2-5 alkynyl, —OH, —O(C 1-5 alkyl), —O(C 1-5 alkylene)-OH, —O(C 1-5 alkylene)-O(C 1-5 alkyl), —SH, —S(C 1-5 alkyl), —NH 2 , —NH(C 1-5 alkyl), —N(C 1-5 alkyl)(C 1-5 alkyl), halogen, C 1-5 haloalkyl, —O—(C 1-5 haloalkyl), —CF 3 , —CN, —NO 2 , —CHO, —CO—(C 1-5 alkyl), —COOH, —CO—O—(C 1-5 alkyl), —O—CO—(C 1-5 alkyl), —CO—NH 2 , —CO—NH(C 1-5 alkyl), —CO—N(C 1-5 alkyl)(C 1-5 alkyl), —NH—CO—(C 1-5 alkyl), —N(C 1-5 alkyl)-CO—(C 1-5 alkyl), —NH—CO—O—(C 1-5 alkyl), —N(C 1-5 alkyl)-CO—O—(C 1-5 alkyl), —O—CO—NH—(C 1-5 alkyl), —O—CO—N(C 1-5 alkyl)-(C 1-5 alkyl), —SO 2 —NH 2 , —SO 2 —NH(C 1-5 alkyl), —SO 2 —N(C 1-5 alkyl)(C 1-5 alkyl), —NH—SO 2 —(C 1-5 alkyl), —N(C 1-5 alkyl)-SO 2 —(C 1-5 alkyl), —SO—(C 1-5 alkyl), —SO 2 —(C 1-5 alkyl), cycloalkyl, and heterocycloalkyl;

each R 12 is independently selected from —OH, —O(C 1-5 alkyl), —O(C 1-5 alkylene)-OH, —O(C 1-5 alkylene)-O(C 1-5 alkyl), —SH, —S(C 1-5 alkyl), —NH 2 , —NH(C 1-5 alkyl), —N(C 1-5 alkyl)(C 1-5 alkyl), halogen, C 1-5 haloalkyl, —O—(C 1-5 haloalkyl), —CF 3 , —CN, —NO 2 , —CHO, —CO—(C 1-5 alkyl), —COOH, —CO—O—(C 1-5 alkyl), —O—CO—(C 1-5 alkyl), —CO—NH 2 , —CO—NH(C 1-5 alkyl), —CO—N(C 1-5 alkyl)(C 1-5 alkyl), —NH—CO—(C 1-5 alkyl), —N(C 1-5 alkyl)-CO—(C 1-5 alkyl), —NH—CO—O—(C 1-5 alkyl), —N(C 1-5 alkyl)-CO—O—(C 1-5 alkyl), —O—CO—NH—(C 1-5 alkyl), —O—CO—N(C 1-5 alkyl)-(C 1-5 alkyl), —SO 2 —NH 2 , —SO 2 —NH(C 1-5 alkyl), —SO 2 —N(C 1-5 alkyl)(C 1-5 alkyl), —NH—SO 2 —(C 1-5 alkyl), —N(C 1-5 alkyl)-SO 2 —(C 1-5 alkyl), —SO—(C 1-5 alkyl), —SO 2 —(C 1-5 alkyl), cycloalkyl, and heterocycloalkyl;

each R 13 is independently selected from C 1-5 alkyl, C 2-5 alkenyl, C 2-5 alkynyl, —(C 0-3 alkylene)-OH, —(C 0-3 alkylene)-O(C 1-5 alkyl), —(C 0-3 alkylene)-O(C 1-5 alkylene)-OH, —(C 0-3 alkylene)-O(C 1-5 alkylene)-O(C 1-5 alkyl), —(C 0-3 alkylene)-SH, —(C 0-3 alkylene)-S(C 1-5 alkyl), —(C 0-3 alkylene)-NH 2 , —(C 0-3 alkylene)-NH(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-halogen, —(C 0-3 alkylene)-(C 1-5 haloalkyl), —(C 0-3 alkylene)-O—(C 1-5 haloalkyl), —(C 0-3 alkylene)-CF 3 , —(C 0-3 alkylene)-CN, —(C 0-3 alkylene)-NO 2 , —(C 0-3 alkylene)-CHO, —(C 0-3 alkylene)-CO—(C 1-5 alkyl), —(C 0-3 alkylene)-COOH, —(C 0-3 alkylene)-CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—(C 1-5 alkyl), —(C 0-3 alkylene)-CO—NH 2 , —(C 0-3 alkylene)-CO—NH(C 1-5 alkyl), —(C 0-3 alkylene)-CO—N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-NH—CO—(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-CO—(C 1-5 alkyl), —(C 0-3 alkylene)-NH—CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—NH—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—N(C 1-5 alkyl)-(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —NH 2 , —(C 0-3 alkylene)-SO 2 —NH(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-NH—SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-SO—(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-cycloalkyl, and —(C 0-3 alkylene)-heterocycloalkyl;

R 2 and R 4 are each independently selected from hydrogen, C 1-5 alkyl, C 2-5 alkenyl, C 2-5 alkynyl, —(C 0-3 alkylene)-OH, —(C 0-3 alkylene)-O(C 1-5 alkyl), —(C 0-3 alkylene)-O(C 1-5 alkylene)-OH, —(C 0-3 alkylene)-O(C 1-5 alkylene)-O(C 1-5 alkyl), —(C 0-3 alkylene)-SH, —(C 0-3 alkylene)-S(C 1-5 alkyl), —(C 0-3 alkylene)-NH 2 , —(C 0-3 alkylene)-NH(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-halogen, —(C 0-3 alkylene)-(C 1-5 haloalkyl), —(C 0-3 alkylene)-O—(C 1-5 haloalkyl), —(C 0-3 alkylene)-CF 3 , —(C 0-3 alkylene)-CN, —(C 0-3 alkylene)-NO 2 , —(C 0-3 alkylene)-CHO, —(C 0-3 alkylene)-CO—(C 1-5 alkyl), —(C 0-3 alkylene)-COOH, —(C 0-3 alkylene)-CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—(C 1-5 alkyl), —(C 0-3 alkylene)-CO—NH 2 , —(C 0-3 alkylene)-CO—NH(C 1-5 alkyl), —(C 0-3 alkylene)-CO—N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-NH—CO—(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-CO—(C 1-5 alkyl), —(C 0-3 alkylene)-NH—CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—NH—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—N(C 1-5 alkyl)-(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —NH 2 , —(C 0-3 alkylene)-SO 2 —NH(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-NH—SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-SO—(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-carbocyclyl, and —(C 0-3 alkylene)-heterocyclyl, wherein the carbocyclyl moiety of said —(C 0-3 alkylene)-carbocyclyl and the heterocyclyl moiety of said —(C 0-3 alkylene)-heterocyclyl are each optionally substituted with one or more groups independently selected from C 1-5 alkyl, C 2-5 alkenyl, C 2-5 alkynyl, —OH, —O(C 1-5 alkyl), —O(C 1-5 alkylene)-OH, —O(C 1-5 alkylene)-O(C 1-5 alkyl), —SH, —S(C 1-5 alkyl), —NH 2 , —NH(C 1-5 alkyl), —N(C 1-5 alkyl)(C 1-5 alkyl), halogen, C 1-5 haloalkyl, —O—(C 1-5 haloalkyl), —CF 3 , —CN, —NO 2 , —CHO, —CO—(C 1-5 alkyl), —COOH, —CO—O—(C 1-5 alkyl), —O—CO—(C 1-5 alkyl), —CO—NH 2 , —CO—NH(C 1-5 alkyl), —CO—N(C 1-5 alkyl)(C 1-5 alkyl), —NH—CO—(C 1-5 alkyl), —N(C 1-5 alkyl)-CO—(C 1-5 alkyl), —NH—CO—O—(C 1-5 alkyl), —N(C 1-5 alkyl)-CO—O—(C 1-5 alkyl), —O—CO—NH—(C 1-5 alkyl), —O—CO—N(C 1-5 alkyl)-(C 1-5 alkyl), —SO 2 —NH 2 , —SO 2 —NH(C 1-5 alkyl), —SO 2 —N(C 1-5 alkyl)(C 1-5 alkyl), —NH—SO 2 —(C 1-5 alkyl), —N(C 1-5 alkyl)-SO 2 —(C 1-5 alkyl), —SO—(C 1-5 alkyl), —SO 2 —(C 1-5 alkyl), cycloalkyl, and heterocycloalkyl;

R 3 is selected from hydrogen, C 1-5 alkyl, C 2-5 alkenyl, C 2-5 alkynyl, —(C 1-5 alkylene)-OH, —(C 1-5 alkylene)-O(C 1-5 alkyl), —(C 1-5 alkylene)-O(C 1-5 alkylene)-OH, —(C 1-5 alkylene)-O(C 1-5 alkylene)-O(C 1-5 alkyl), —(C 1-5 alkylene)-SH, —(C 1-5 alkylene)-S(C 1-5 alkyl), —(C 1-5 alkylene)-NH 2 , —(C 1-5 alkylene)-NH(C 1-5 alkyl), —(C 1-5 alkylene)-N(C 1-5 alkyl)(C 1-5 alkyl), —(C 1-5 alkylene)-halogen, C 1-5 haloalkyl, —(C 1-5 alkylene)-O—(C 1-5 haloalkyl), —(C 1-5 alkylene)-CF 3 , —(C 1-5 alkylene)-CN, —(C 1-5 alkylene)-NO 2 , —(C 1-5 alkylene)-Si(C 1-5 alkyl) 3 , —(C 1-5 alkylene)-O(C 1-5 alkylene)-Si(C 1-5 alkyl) 3 , —(C 1-5 alkylene)-CHO, —(C 1-5 alkylene)-CO—(C 1-5 alkyl), —(C 1-5 alkylene)-COOH, —(C 1-5 alkylene)-CO—O—(C 1-5 alkyl), —(C 1-5 alkylene)-O—CO—(C 1-5 alkyl), —(C 1-5 alkylene)-CO—NH 2 , —(C 1-5 alkylene)-CO—NH(C 1-5 alkyl), —(C 1-5 alkylene)-CO—N(C 1-5 alkyl)(C 1-5 alkyl), —(C 1-5 alkylene)-NH—CO—(C 1-5 alkyl), —(C 1-5 alkylene)-N(C 1-5 alkyl)-CO—(C 1-5 alkyl), —(C 1-5 alkylene)-NH—CO—O—(C 1-5 alkyl), —(C 1-5 alkylene)-N(C 1-5 alkyl)-CO—O—(C 1-5 alkyl), —(C 1-5 alkylene)-O—CO—NH—(C 1-5 alkyl), —(C 1-5 alkylene)-O—CO—N(C 1-5 alkyl)-(C 1-5 alkyl), —(C 1-5 alkylene)-SO 2 —NH 2 , —(C 1-5 alkylene)-SO 2 —NH(C 1-5 alkyl), —(C 1-5 alkylene)-SO 2 —N(C 1-5 alkyl)(C 1-5 alkyl), —(C 1-5 alkylene)-NH—SO 2 —(C 1-5 alkyl), —(C 1-5 alkylene)-N(C 1-5 alkyl)-SO 2 —(C 1-5 alkyl), —(C 1-5 alkylene)-SO—(C 1-5 alkyl), —(C 1-5 alkylene)-SO 2 —(C 1-5 alkyl), —(C 0-5 alkylene)-carbocyclyl, and —(C 0-5 alkylene)-heterocyclyl, wherein the carbocyclyl moiety of said —(C 0-5 alkylene)-carbocyclyl and the heterocyclyl moiety of said —(C 0-5 alkylene)-heterocyclyl are each optionally substituted with one or more groups independently selected from C 1-5 alkyl, C 2-5 alkenyl, C 2-5 alkynyl, —OH, —O(C 1-5 alkyl), —O(C 1-5 alkylene)-OH, —O(C 1-5 alkylene)-O(C 1-5 alkyl), —SH, —S(C 1-5 alkyl), —NH 2 , —NH(C 1-5 alkyl), —N(C 1-5 alkyl)(C 1-5 alkyl), halogen, C 1-5 haloalkyl, —O—(C 1-5 haloalkyl), —CF 3 , —CN, —NO 2 , —CHO, —CO—(C 1-5 alkyl), —COOH, —CO—O—(C 1-5 alkyl), —O—CO—(C 1-5 alkyl), —CO—NH 2 , —CO—NH(C 1-5 alkyl), —CO—N(C 1-5 alkyl)(C 1-5 alkyl), —NH—CO—(C 1-5 alkyl), —N(C 1-5 alkyl)-CO—(C 1-5 alkyl), —NH—CO—O—(C 1-5 alkyl), —N(C 1-5 alkyl)-CO—O—(C 1-5 alkyl), —O—CO—NH—(C 1-5 alkyl), —O—CO—N(C 1-5 alkyl)-(C 1-5 alkyl), —SO 2 —NH 2 , —SO 2 —NH(C 1-5 alkyl), —SO 2 —N(C 1-5 alkyl)(C 1-5 alkyl), —NH—SO 2 —(C 1-5 alkyl), —N(C 1-5 alkyl)-SO 2 —(C 1-5 alkyl), —SO—(C 1-5 alkyl), —SO 2 —(C 1-5 alkyl), cycloalkyl, and heterocycloalkyl;

ring A is a bicyclic heteroaryl, wherein said bicyclic heteroaryl is optionally substituted with one or more groups R A ; and

each R A is independently selected from C 1-5 alkyl, C 2-5 alkenyl, C 2-5 alkynyl, —(C 0-3 alkylene)-OH, —(C 0-3 alkylene)-O(C 1-5 alkyl), —(C 0-3 alkylene)-O(C 1-5 alkylene)-OH, —(C 0-3 alkylene)-O(C 1-5 alkylene)-O(C 1-5 alkyl), —(C 0-3 alkylene)-SH, —(C 0-3 alkylene)-S(C 1-5 alkyl), —(C 0-3 alkylene)-NH 2 , —(C 0-3 alkylene)-NH(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-halogen, —(C 0-3 alkylene)-(C 1-5 haloalkyl), —(C 0-3 alkylene)-O—(C 1-5 haloalkyl), —(C 0-3 alkylene)-CF 3 , —(C 0-3 alkylene)-CN, —(C 0-3 alkylene)-NO 2 , —(C 0-3 alkylene)-CHO, —(C 0-3 alkylene)-CO—(C 1-5 alkyl), —(C 0-3 alkylene)-COOH, —(C 0-3 alkylene)-CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—(C 1-5 alkyl), —(C 0-3 alkylene)-CO—NH 2 , —(C 0-3 alkylene)-CO—NH(C 1-5 alkyl), —(C 0-3 alkylene)-CO—N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-NH—CO—(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-CO—(C 1-5 alkyl), —(C 0-3 alkylene)-NH—CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-CO—O—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—NH—(C 1-5 alkyl), —(C 0-3 alkylene)-O—CO—N(C 1-5 alkyl)-(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —NH 2 , —(C 0-3 alkylene)-SO 2 —NH(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —N(C 1-5 alkyl)(C 1-5 alkyl), —(C 0-3 alkylene)-NH—SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-N(C 1-5 alkyl)-SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-SO—(C 1-5 alkyl), —(C 0-3 alkylene)-SO 2 —(C 1-5 alkyl), —(C 0-3 alkylene)-carbocyclyl, and —(C 0-3 alkylene)-heterocyclyl, wherein the carbocyclyl moiety of said —(C 0-3 alkylene)-carbocyclyl and the heterocyclyl moiety of said —(C 0-3 alkylene)-heterocyclyl are each optionally substituted with one or more groups independently selected from C 1-5 alkyl, C 2-5 alkenyl, C 2-5 alkynyl, —OH, —O(C 1-5 alkyl), —O(C 1-5 alkylene)-OH, —O(C 1-5 alkylene)-O(C 1-5 alkyl), —SH, —S(C 1-5 alkyl), —NH 2 , —NH(C 1-5 alkyl), —N(C 1-5 alkyl)(C 1-5 alkyl), halogen, C 1-5 haloalkyl, —O—(C 1-5 haloalkyl), —CF 3 , —CN, —NO 2 , —CHO, —CO—(C 1-5 alkyl), —COOH, —CO—O—(C 1-5 alkyl), —O—CO—(C 1-5 alkyl), —CO—NH 2 , —CO—NH(C 1-5 alkyl), —CO—N(C 1-5 alkyl)(C 1-5 alkyl), —NH—CO—(C 1-5 alkyl), —N(C 1-5 alkyl)-CO—(C 1-5 alkyl), —NH—CO—O—(C 1-5 alkyl), —N(C 1-5 alkyl)-CO—O—(C 1-5 alkyl), —O—CO—NH—(C 1-5 alkyl), —O—CO—N(C 1-5 alkyl)-(C 1-5 alkyl), —SO 2 —NH 2 , —SO 2 —NH(C 1-5 alkyl), —SO 2 —N(C 1-5 alkyl)(C 1-5 alkyl), —NH—SO 2 —(C 1-5 alkyl), —N(C 1-5 alkyl)-SO 2 —(C 1-5 alkyl), —SO—(C 1-5 alkyl), —SO 2 —(C 1-5 alkyl), cycloalkyl, and heterocycloalkyl;

or a pharmaceutically acceptable salt, solvate or prodrug thereof.

2 . The compound of claim 1 , wherein R 1A and R 1B are mutually linked to form, together with the nitrogen atom that they are attached to, a heterocycloalkyl which is optionally substituted with one or more groups R 11 .

3 . The compound of claim 1 , R 1A and R 1B are mutually linked to form, together with the nitrogen atom that they are attached to, a group which is selected from

wherein each one of the above-depicted groups is optionally substituted with one or more R 11 .

4 . The compound of claim 1 , wherein R 2 and R 4 are each independently selected from hydrogen, C 1-5 alkyl, —OH, —O(C 1-5 alkyl), —O(C 1-5 alkylene)-OH, —O(C 1-5 alkylene)-O(C 1-5 alkyl), —SH, —S(C 1-5 alkyl), —NH 2 , —NH(C 1-5 alkyl), —N(C 1-5 alkyl)(C 1-5 alkyl), halogen, C 1-5 haloalkyl, —CF 3 , and —CN.

5 . The compound of claim 1 , wherein R 3 is selected from C 1-5 haloalkyl, —(C 1-5 alkylene)-CN, —(C 1-5 alkylene)-SO—(C 1-5 alkyl), and —(C 1-5 alkylene)-SO 2 —(C 1-5 alkyl).

6 . The compound of claim 1 , wherein R 3 is —CH 2 —CF 3 or —CH 2 —SO 2 —CH 3 .

7 . The compound of claim 1 , wherein ring A is a fused bicyclic heteroaryl, wherein one of the two fused rings of said fused bicyclic heteroaryl has 5 ring atoms and the other fused ring has 6 ring atoms, and further wherein said bicyclic heteroaryl is optionally substituted with one or more groups R A .

8 . The compound of claim 1 , wherein ring A is a bicyclic heteroaryl having the following formula (II):

wherein each of the two fused rings of said bicyclic heteroaryl is aromatic,

wherein each ring atom A of the bicyclic heteroaryl is independently a carbon or nitrogen atom, wherein each ring atom B is independently a carbon, nitrogen, oxygen or sulfur atom, wherein at least one of the ring atoms A and/or B is different from carbon, and wherein said bicyclic heteroaryl is optionally substituted with one or more groups R A .

9 . The compound of claim 1 , wherein ring A is selected from any one of the following groups:

wherein each of the above-depicted groups is optionally substituted with one or more groups R A ;

and preferably wherein ring A is selected from any one of the following groups:

wherein each of the above-depicted groups is optionally substituted with one or more groups R A .

10 . The compound of claim 1 , wherein each R A is independently selected from C 1-5 alkyl, —OH, —O(C 1-5 alkyl), —O(C 1-5 alkylene)-OH, —O(C 1-5 alkylene)-O(C 1-5 alkyl), —SH, —S(C 1-5 alkyl), —NH 2 , —NH(C 1-5 alkyl), —N(C 1-5 alkyl)(C 1-5 alkyl), halogen, C 1-5 haloalkyl, —CF 3 , and —CN; preferably wherein each R A is independently halogen; and more preferably wherein each R A is —F.

11 . The compound of claim 1 , wherein said compound is selected from:

1

[3-(1-Methyl-1H-indol-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridine-6-yl]-1,4-oxazepan-4-yl-methanone

2

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2-

methanesulfonyl-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

3

Azepan-1-yl-[1-(2,2-difluoro-ethyl)-3-(6-fluoro-imidazo[1,2-

a]pyridin-3-yl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

4

Azepan-1-yl-[1-(2-fluoro-ethyl)-3-(6-fluoro-imidazo[1,2-

a]pyridin-3-yl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methenone

5

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-propyl-

1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

6

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-

methoxymethyl-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

7

[6-(Azepane-1-carbonyl)-3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-

pyrazolo[4,3-c]pyridin-1-yl]-acetonitrile

8

Azepan-1-yl-[3-(6,8-difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2-

methoxy-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

9

[1-Cyclopropylmethyl-3-(6,8-difluoro-imidazo[1,2-a]pyridin-3-

yl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-1,4-oxazepan-4-yl-methanone

10

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-methanesulfonyl-

1H-pyrazolo[4,3-c]pyridin-6-yl]-1,4-oxazepan-4-yl-methanone

11

3-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-6-(1,4-oxazepane-

4-carbonyl)-pyrazolo[4,3-c]pyridin-1-ylmethyl]-azetidine-1-

carboxylic acid tert-butyl ester

12

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-hydroxymethyl-

1H-pyrazolo[4,3-c]pyridin-6-yl]-1,4-oxazepan-4-yl-methanone

13

[3-Benzofuran-3-yl-6-(1,4-oxazepane-4-carbonyl)-pyrazolo[4,3-

c]pyridin-1-yl]-acetonitrile

14

(3-Aza-bicyclo[3.2.1]oct-3-yl)-[3-(6,8-difluoro-imidazo[1,2-

a]pyridin-3-yl)-1-methylsulfanylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl]-methanone

15

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-

methanesulfonylmethyl-1H-pyrazolo[4,3-c]pyridin-6-yl]-1,4-

oxazepan-4-yl-methanone

16

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridine-6-yl)-1,4-oxazepan-4-yl-methanone

17

(1-Methanesulfonylmethyl-3-pyrazolo[1,5-a]pyridin-3-yl-1H-

pyrazolo[4,3-c]pyridin-6-yl)-1,4-oxazepan-4-yl-methanone

18

(3-Aza-bicyclo[3.2.1]oct-3-yl)-(1-methanesulfonylmethyl-3-

pyrazolo[1,5-a]pyridin-3-yl-1H-pyrazolo[4,3-c]pyridin-6-yl)-

methanone

19

(3-Aza-bicyclo[3.2.1]oct-3-yl)-(3-benzofuran-3-yl-1-

methanesulfonylmethyl-1H-pyrazolo[4,3-c]pyridin-6-yl)-

methanone

20

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-

methanesulfonylmethyl-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

21

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-

methanesulfinylmethyl-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

22

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-

ethanesulfonylmethyl-1H-pyrazolo[4,3-c]pyridin-6-yl]-1,4-

oxazepan-4-yl-methanone

23

(3-Aza-bicyclo[3.2.1]oct-3-yl)-[3-(6,8-difluoro-imidazo[1,2-

a]pyridin-3-yl)-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl]-methanone

24

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-

methanesulfonylmethyl-1H-pyrazolo[4,3-c]pyridin-6-yl]-(8-endo-

hydroxy-8-exo-methyl-3-aza-bicyclo[3.2.1]oct-3-yl)-methanone

25

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-

methanesulfonylmethyl-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-endo-

hydroxy-8-aza-bicyclo[3.2.1]oct-8-yl)-methanone

26

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-

methanesulfonylmethyl-1H-pyrazolo[4,3-c]pyridin-6-yl]-(2-oxa-5-

aza-bicyclo[2.2.1]hept-5-yl)-methanone

27

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-

methanesulfonylmethyl-1H-pyrazolo[4,3 c]pyridin-6-yl]-(8-oxa-3-

aza-bicyclo[3.2.1]oct-3-yl)-methanone

28

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(8-endo-hydroxy-8-exo-methyl-d3-3-aza-

bicyclo[3.2.1]oct-3-yl)-methanone

29

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(6,6-difluoro-1,4-oxazepan-4-yl)-methanone

30

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(8-endo-hydroxy-3-aza-bicyclo[3.2.1]oct-3-yl)-

methanone

31

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(5-endo-hydroxy-5-exo-methyl-2-aza-

bicyclo[2.2.1]hept-2-yl)-methanone

32

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(4-hydroxy-4-methyl-piperidin-1-yl)-methanone

33

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(4,4-difluoro-piperidin-1-yl)-methanone

34

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(2-methoxymethyl-pyrrolidin-1-yl)-methanone

35

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(4-hydroxy-2,2 dimethyl-piperidin-1-yl)-

methanone

36

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(4-hydroxy-piperidin-1-yl)-methanone

37

[3-(benzofuran-3-yl)-1-(methylsulfonylmethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(3-endo-hydroxy-8-azabicyclo[3.2.1]octan-8-

yl)methanone

38

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(3-hydroxy-piperidin-1-yl)-methanone

39

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(3,3-difluoro-piperidin-1-yl)-methanone

40

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridin-6-yl)-(4-hydroxyazepan-1-yl)-methanone

41

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-methyl-

1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

42

3-[6-(Azepane-1-carbonyl)-1-methyl-1H-pyrazolo[4,3-c]pyridin-3-

yl]-imidazo[1,2-a]pyridine-6-carbonitrile

43

3-[6-(Azepane-1-carbonyl)-1-propyl-1H-pyrazolo[4,3-c]pyridin-3-

yl]-imidazo[1,2-a]pyridine-6-carbonitrile

44

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

45

3-[6-(Azepane-1-carbonyl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-3-yl]-imidazo[1,2-a]pyridine-6-carbonitrile

46

3-[6-(Azepane-1-carbonyl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]-pyridin-3-yl]-imidazo[1,2-a]pyridine-6-carboxylic

acid amide

47

3-[6-(Azepane-1-carbonyl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-3-yl]-8-methyl-imidazo[1,2-a]pyridine-6-

carbonitrile

48

Azepan-1-yl-[3-(6-chloro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

49

3-[6-(Azepane-1-carbonyl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-3-yl]-imidazo[1,2-a]pyridine-6-carboxylic

acid methylamide

50

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyrimidin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

51

Azepan-1-yl-[3-(6-methoxymethyl-imidazo[1,2-a]pyridin-3-yl)-1-

(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

52

Azepan-1-yl-[3-indolizin-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-6-yl]-methanone

53

3-[6-(Azepane-1-carbonyl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-3-yl]-imidazo[1,2-a]pyridine-6-carboxylic

acid dimethylamide

54

Azepan-1-yl-[3-imidazo[1,5-a]pyridin-3-yl-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

55

Azepan-1-yl-[3-imidazo[1,2-a]pyridin-3-yl-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

56

Azepan-1-yl-[3-imidazo[1,2-a]pyrazin-3-yl-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

57

3-[6-(Azepane-1-carbonyl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-3-yl]-7-methyl-imidazo[1,2-a]pyridine-6-

carboxylic acid amide

58

Azepan-1-yl-[1-(2,2,2-trifluoro-ethyl)-3-(6-trifluoromethyl-

imidazo[1,2-a]pyridin-3-yl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

59

Azepan-1-yl-[3-(6-methoxy-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

60

Azepan-1-yl-[3-(6,8-difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

61

Azepan-1-yl-[3-(6-methyl-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

62

Azepan-1-yl-[3-(8-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

63

3-[6-(Azepane-1-carbonyl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-3-yl]-7-hydroxy-imidazo[1,2-a]pyridine-6-

carbonitrile

64

Azepan-1-yl-[3-[6-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-3-yl]-

1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

65

Azepan-1-yl-[3-(6-cyclopropyl-imidazo[1,2-a]pyridin-3-yl)-1-

(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

66

Azepan-1-yl-[1-(2,2,2-trifluoro-ethyl)-3-(6-trifluoromethoxy-

imidazo[1,2-a]pyridin-3-yl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

67

Azepan-1-yl-[3-(7-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

68

Azepan-1-yl-[3-(6-hydroxy-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

69

Azepan-1-yl-[3-(6-difluoromethyl-imidazo[1,2-a]pyridin-3-yl)-1-

(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

70

Azepan-1-yl-[3-[6-(2,2,2-trifluoro-ethoxy)-imidazo[1,2-a]pyridin-

3-yl]-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

71

Azepan-1-yl-[3-[1,2,4]triazolo[4,3-a]pyridin-3-yl-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

72

Azepan-1-yl-[3-[6-(1-hydroxy-1-methyl-ethyl)-imidazo[1,2-

a]pyridin-3-yl]-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-methanone

73

Azepan-1-yl-[3-(7-chloro-6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-

(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

74

Azepan-1-yl-[3-(6-chloro-7-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-

(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

75

Azepan-1-yl-[3-(6-chloro-7-hydroxy-imidazo[1,2-a]pyridin-3-yl)-

1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

76

Azepan-1-yl-[3-(6,8-difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2-

trimethylsilanyl-ethoxymethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

77

Azepan-1-yl-[3-(6-fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2-

trimethylsilanyl-ethoxymethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

78

Azepan-1-yl-[3-(6,8-difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(4-

methoxy-benzyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

79

Azepan-1-yl-[3-(6,8-difluoro-imidazo[1,2-a]pyridin-3-yl)-1-

(tetrahydro-pyran-2-yl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

80

[3-(6-Fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-

1H-pyrazolo[4,3-c]pyridin-6-yl]-1,4-oxazepan-4-yl-methanone

81

3-[6-(1,4-Oxazepane-4-carbonyl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-3-yl]-imidazo[1,2-a]pyridine-6-carbonitrile

82

[3-(6-Fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-

1H-pyrazolo[4,3-c]pyridin-6-yl]-(8-oxa-3-aza-bicyclo[3.2.1]oct-3-

yl)-methanone

83

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3c]pyridin-6-yl]-(8-oxa-3-aza-

bicyclo[3.2.1]oct-3-yl)-methanone

84

3-[6-(8-Oxa-3-aza-bicyclo[3.2.1]octane-3-carbonyl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-3-yl]-imidazo[1,2-

a]pyridine-6-carbonitrile

85

[3-(8-fluoroimidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]-(3-endo-hydroxy-8-

azabicyclo[3.2.1]octan-8-yl)methanone

86

[3-(6-fluoroimidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]-(3-endo-hydroxy-8-

azabicyclo[3.2.1]octan-8-yl)methanone

87

[3-(imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]-(3-endo-hydroxy-8-

azabicyclo[3.2.1]octan-8-yl)methanone

88

(3-endo-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)-[3-(6-

hydroxyimidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]methanone

89

Azepan-1-yl-[3-pyrazolo[1,5-a]pyridin-3-yl-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone hydrochloride

90

Azepan-1-yl-[3-benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-6-yl]-methanone

91

Azepan-1-yl-[3-(1H-indol-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-6-yl]-methanone

92

Azepan-1-yl-[3-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

93

1,4-Oxazepan-4-yl-[3-thieno[2,3-c]pyridin-3-yl-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

94

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridine-6-yl]-1,4-oxazepan-4-yl-methanone

95

1,4-Oxazepan-4-yl-[3-pyrazolo[1,5-a]pyridine-3-yl-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridine-6-yl]-methanone

96

[3-(1H-Indol-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridine-6-yl]-1,4-oxazepan-4-yl-methanone

97

1,4-Oxazepan-4-yl-[3-(1H-pyrrolo[2,3-b]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridine-6-yl]-methanone

98

[3-Benzo[b]thiophen-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridine-6-yl]-1,4-oxazepan-4-yl-methanone

99

(8-Oxa-3-aza-bicyclo[3.2.1]oct-3-yl)-[3-pyrazolo[1,5-a]pyridin-3-

yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

100

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(8-oxa-3-aza-bicyclo[3.2.1]oct-3-yl)-methanone

101

(3-Aza-bicyclo[3.2.1]oct-3-yl)-[3-benzofuran-3-yl-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

102

(3-Aza-bicyclo[3.2.1]oct-3-yl)-[3-pyrazolo[1,5-a]pyridin-3-yl-1-

(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

103

[3-Benzofuran-3-yl-1-(2,2-difluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-1,4-oxazepan-4-yl-methanone

104

[3-Benzofuran-3-yl-1-(2-fluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-

6-yl]-1,4-oxazepan-4-yl-methanone

105

2-[3-Benzofuran-3-yl-6-(1,4-oxazepane-4-carbonyl)-pyrazolo[4,3-

c]pyridin-1-yl]-acetamide

106

(3-Benzofuran-3-yl-1-propyl-1H-pyrazolo[4,3-c]pyridin-6-yl)-1,4-

oxazepan-4-yl-methanone

107

(3-Benzofuran-3-yl-1-methanesulfonylmethyl-1H-pyrazolo[4,3-

c]pyridine-6-yl)-(8-oxa-3-aza-bicyclo[3.2.1]oct-3-yl)-methanone

108

(1-Methanesulfonylmethyl-3-pyrazolo[1,5-a]pyridine-3-yl-1H-

pyrazolo[4,3-c]pyridine-6-yl)-(8-oxa-3-aza-bicyclo[3.2.1]oct-3-

yl)-methanone

109

[3-(5-fluorobenzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(1,4-oxazepan-4-yl)methanone

110

[3-(5-fluorobenzofuran-3-yl)-1-

(methylsulfonylmethyl)pyrazolo[4,3-c]pyridin-6-yl]-(1,4-

oxazepan-4-yl)methanone

111

[3-(5-fluorobenzofuran-3-yl)-1-

(methylsulfonylmethyl)pyrazolo[4,3-c]pyridin-6-yl]-(8-oxa-3-

azabicyclo[3.2.1]octan-3-yl)methanone

112

(3-endo-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)-[3-(1H-indol-3-

yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]methanone

113

(3-endo-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)-[3-pyrazolo[1,5-

a]pyridin-3-yl-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-c]pyridin-6-

yl]methanone

114

(4-hydroxy-1-piperidyl)-[3-pyrazolo[1,5-a]pyridin-3-yl-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]methanone

115

[3-(5-fluorobenzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(4-hydroxy-1-piperidyl)methanone

116

[3-(5-fluorobenzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(4-hydroxy-4-methyl-1-piperidyl)methanone

117

(4-hydroxy-4-methyl-1-piperidyl)-[3-pyrazolo[1,5-a]pyridin-3-yl-

1-(2,2,2-trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]methanone

118

[3-(5-fluorobenzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(6-hydroxy-1,4-oxazepan-4-yl)methanone

119

(6-hydroxy-1,4-oxazepan-4-yl)-[3-pyrazolo[1,5-a]pyridin-3-yl-1-

(2,2,2-trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]methanone

120

[3-(5-fluorobenzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(6,6-dideuterio-1,4-oxazepan-4-yl)methanone

121

(6,6-dideuterio-1,4-oxazepan-4-yl)-[3-pyrazolo[1,5-a]pyridin-3-yl-

1-(2,2,2-trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]methanone

122

[3-(5-fluorobenzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(4-hydroxyazepan-1-yl)methanone

123

[3-(5-fluoro-1H-indol-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(1,4-oxazepan-4-yl)methanone

124

methyl 3-[6-(1,4-oxazepane-4-carbonyl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridin-3-yl]benzofuran-5-

carboxylate

125

[3-(5-methylbenzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(1,4-oxazepan-4-yl)methanone

126

[3-(2-methylbenzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(1,4-oxazepan-4-yl)methanone

127

[3-(5-fluorobenzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)methanone

128

3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carboxylic acid amide

129

3-[6-(1,4-oxazepane-4-carbonyl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridin-3-yl]benzofuran-5-carboxylic

acid

130

1-[3-(benzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridine-6-carbonyl]piperidine-4-carboxylic acid

131

[3-(6-Fluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-

1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxy-piperidin-1-yl)-

methanone

132

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxy-piperidin-1-yl)-

methanone

133

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxy-4-methyl-

piperidin-1-yl)-methanone

134

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-hydroxy-azepan-1-yl)-

methanone

135

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(2-oxa-5-aza-

bicyclo[2.2.1]hept-5-yl)-methanone

136

[3-(6,8-Difluoro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-hydroxy-8-aza-

bicyclo[3.2.1]oct-8-yl)-methanone

137

[3-(6,8-Difluoro-[1,2,4]triazolo[4,3-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-1,4-oxazepan-4-

yl-methanone

138

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxy-2-methyl-

piperidin-1-yl)-methanone

139

(3-Aza-bicyclo[3.2.1]oct-3-yl)-[3-(6,8-difluoro-imidazo[1,2-

a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-methanone

140

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(9-hydroxy-3-aza-

bicyclo[3.3.1]non-3-yl)-methanone

141

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxy-2-isopropyl-

piperidin-1-yl)-methanone

142

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxy-2,2-dimethyl-

piperidin-1-yl)-methanone

143

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxy-3-isobutyl-

piperidin-1-yl)-methanone

144

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-fluoro-piperidin-1-yl)-

methanone

145

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(8-oxa-2-aza-

spiro[4.5]dec-2-yl)-methanone

146

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4,4-difluoro-piperidin-1-

yl)-methanone

147

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4′-hydroxy-3′,4′,5′,6′-

tetrahydro-2′H-[3,4′]bipyridinyl-1′-yl)-methanone

148

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxy-4-

trifluoromethyl-piperidin-1-yl)-methanone

149

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(2-methoxymethyl-

pyrrolidin-1-yl)-methanone

150

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-methyl-1,4-diazepan-1-

yl)-methanone

151

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-hydroxy-piperidin-1-yl)-

methanone

152

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(7-oxa-2-aza-

spiro[4.5]dec-2-yl)-methanone

153

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-oxa-9-aza-

spiro[5.5]undec-9-yl)-methanone

154

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(tetrahydro-furo[3,4-

c]pyrrol-5-yl)-methanone

155

8-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carbonyl]-2,8-diaza-

spiro[4.5]decan-3-one

156

8-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carbonyl]-2,8-diaza-

spiro[4.5]decan-1-one

157

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-[3-(2-methoxy-ethyl)-

pyrrolidin-1-yl]-methanone

158

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-morpholin-4-yl-methanone

159

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3,3-difluoro-piperidin-1-

yl)-methanone

160

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3,3-difluoro-piperidin-1-

yl)-methanone

161

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-hydroxymethyl-

piperidin-1-yl)-methanone

162

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(8-endo-hydroxy-8-exo-

methyl-3-aza-bicyclo[3.2.1]oct-3-yl)-methanone

163

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(2-trifluoromethyl-

morpholin-4-yl)-methanone

164

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-trifluoromethyl-

piperidin-1-yl)-methanone

165

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxymethyl-

piperidin-1-yl)-methanone

166

[3-(6,8-Difluoro-imidazo[l,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(2-oxa-7-aza-

spiro[3.5]non-7-yl)-methanone

167

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-methoxymethyl-

morpholin-4-yl)-methanone

168

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-endo-hydroxy-8-aza-

bicyclo[3.2.1]oct-8-yl)-methanone

169

(4-Aza-tricyclo[4.3.1.1*3,8*]undec-4-yl)-[3-(6,8-difluoro-

imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-6-yl]-methanone

170

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(8-exo-hydroxy-3-aza-

bicyclo[3.2.1]oct-3-yl)-methanone

171

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-exo-hydroxy-8-aza-

bicyclo[3.2.1]oct-8-yl)-methanone

172

(8-Aza-bicyclo[3.2.1]oct-8-yl)-[3-(6,8-difluoro-imidazo[1,2-

a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-methanone

173

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-difluoromethyl-

piperidin-1-yl)-methanone

174

3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carboxylic acid (2-hydroxy-2-

methyl-propyl)-amide

175

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(2-oxa-6-aza-

tricyclo[3.3.1.1*3,7*]dec-6-yl)-methanone

176

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxymethyl-4-

methyl-piperidin-1-yl)-methanone

177

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(4-hydroxy-azepan-1-yl)-

methanone

178

(2-Aza-tricyclo[3.3.1.1*3,7*]dec-2-yl)-[3-(6,8-difluoro-

imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-6-yl]-methanone

179

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(5-oxa-8-aza-

spiro[2.6]non-8-yl)-methanone

180

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-1,4-thiazepan-1,1-dioxide-

4-yl-methanone

181

Cis-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(2,6-dimethyl-

morpholin-4-yl)-methanone

182

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(2,2-dimethyl-1,4-

oxazepan-4-yl)-methanone

183

Cis-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3,5-dimethyl-

morpholin-4-yl)-methanone

184

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(3-oxa-8-aza-

bicyclo[3.2.1]oct-8-yl)-methanone

185

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(6,6-difluoro-1,4-

oxazepan-4-yl)-methanone

186

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(8-oxa-4-aza-

spiro[2.6]non-4-yl)-methanone

187

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(8-endo-hydroxy-3-aza-

bicyclo[3.2.1]oct-3-yl)-methanone

188

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(7-endo-hydroxy-3-oxa-9-

aza-bicyclo[3.3.1]non-9-yl)-methanone

189

1-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carbonyl]-1,4-diazepan-5-one

190

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-1,4-oxazepan-deuterium-4-

yl-methanone

191

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-[1,2]oxazepan-2-yl-

methanone

192

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(5-oxa-8-aza-

spiro[3.5]non-8-yl)-methanone

193

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(6-hydroxy-1,4-oxazepan-

4-yl)-methanone

194

5-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carbonyl]-2,5-diaza-

bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester

195

1,4-Diazepan-1-yl-[3-(6,8-difluoro-imidazo[1,2-a]pyridin-3-yl)-1-

(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

196

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(8-oxa-5-aza-

spiro[3.5]non-5-yl)-methanone

197

(2-{[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carbonyl]-methyl-

amino}-ethyl)-carbamic acid tert-butyl ester

198

3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carboxylic acid (4-hydroxy-

tetrahydro-pyran-3-yl)-amide

199

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(6-oxa-3-aza-

bicyclo[3.2.1]oct-3-yl)-methanone

200

3-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carbonyl]-3,8-diaza-

bicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester

201

4-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carbonyl]-1,4-diazepan-2-one

202

{1-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trilluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carbonyl]-azepan-3-yl}-

carbamic acid tert-butyl ester

203

(3,3-Difluoro-4-hydroxy-piperidin-1-yl)-[3-(6,8-difluoro-

imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-6-yl]-methanone

204

{4-[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridine-6-carbonyl]-1,4-oxazepan-6-

yl}-carbamic acid tert-butyl ester

205

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(2-oxa-5-aza-

bicyclo[4.1.0]hept-5-yl)-methanone

206

[3-(6,8-Difluoro-imidazo[1,2-a]pyridin-3-yl)-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-(7-oxa-4-aza-

spiro[2.6]non-4-yl)-methanone

207

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(4-hydroxy-piperidin-1-yl)-methanone

208

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(4-hydroxy-4-methyl-piperidin-1-yl)-methanone

209

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(3-endo-hydroxy-8-aza-bicyclo[3.2.1]oct-8-yl)-

methanone

210

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(8-exo-ethyl-8-endo-hydroxy-3-aza-

bicyclo[3.2.1]oct-3-yl)-methanone

211

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(5-endo-hydroxy-5-exo-methyl-2-aza-

bicyclo[2.2.1]hept-2-yl)-methanone

212

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(8-endo-hydroxy-8-exo-methyl-3-aza-

bicyclo[3.2.1]oct-3-yl)-methanone

213

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(8-endo-hydroxy-8-exo-methyl-d3-3-aza-

bicyclo[3.2.1]oct-3-yl)-methanone

214

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(8-exo-ethynyl-8-endo-hydroxy-3-aza-

bicyclo[3.2.1]oct-3-yl)-methanone

215

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(2-methoxymethyl-pyrrolidin-1-yl)-methanone

216

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(4-fluoro-piperidin-1-yl)-methanone

217

3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(6,6-difluoro-1,4-oxazepan-4-yl)-methanone

218

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(8-endo-hydroxy-3-aza-bicyclo[3.2.1]oct-3-yl)-

methanone

219

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(4-hydroxy-2,2-dimethyl-piperidin-1-yl)-

methanone

220

[3-Benzofuran-3-yl-1-(2,2-difluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(3-endo-hydroxy-8-aza-bicyclo[3.2.1]oct-8-yl)-

methanone

221

[3-Benzofuran-3-yl-1-(2-fluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-

6-yl]-(3-endo-hydroxy-8-aza-bicyclo[3.2.1]oct-8-yl)-methanone

222

(3-Benzofuran-3-yl-1-propyl-1H-pyrazolo[4,3-c]pyridin-6-yl)-(3-

endo-hydroxy-8-aza-bicyclo[3.2.1]oct-8-yl)-methanone

223

tert-butyl N-[4-[3-(6,8-difluoroimidazo[1,2-a]pyridin-3-yl)-1-

(2,2,2-trifluoroethyl)pyrazolo[4,3-c]pyridine-6-carbonyl]-1,4-

oxazepan-6-yl]carbamate

224

[3-(benzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(6-hydroxy-1,4-oxazepan-4-yl)methanone

225

[3-(benzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(4,4-difluoro-1-piperidyl)methanone

226

[3-(benzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(3,3-difluoro-1-piperidyl)methanone

227

[3-Benzofuran-3-yl-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-(3-hydroxy-piperidin-1-yl)-methanone

228

[3-(benzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(4-hydroxyazepan-1-yl)methanone

229

[3-(benzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(6,6-dideuterio-1,4-oxazepan-4-yl)methanone

230

[3-(benzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-[6-fluoro-1,4-oxazepan-4-yl]methanone

231

3-(benzofuran-3-yl)-N,N-di(cyclobutyl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridine-6-carboxamide

232

3-(benzofuran-3-yl)-N,N-di(cyclopropyl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridine-6-carboxamide

233

3-(benzofuran-3-yl)-N,N-diisopropyl-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridine-6-carboxamide

234

3-(benzofuran-3-yl)-N-ethyl-N-isopropyl-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridine-6-carboxamide

235

3-(benzofuran-3-yl)-N-cyclohexyl-N-ethyl-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridine-6-carboxamide

236

[3-(benzofuran-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(8-hydroxy-8-isopropyl-3-azabicyclo[3.2.1]octan-

3-yl)methanone

237

3-[6-(1,4-oxazepane-4-carbonyl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridin-3-yl]benzofuran-5-

carboxamide

238

(3,8-Diaza-bicyclo[3.2.1]oct-3-yl)-[3-(6,8-difluoro-imidazo[1,2-

a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-methanone

239

(2,5-Diaza-bicyclo[2.2.1]hept-2-yl)-[3-(6,8-difluoro-imidazo[l,2-

a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-methanone

240

(3-Amino-azepan-1-yl)-[3-(6,8-difluoro-imidazo[1,2-a]pyridin-3-

yl)-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-

methanone

241

(6-Amino-1,4-oxazepan-4-yl)-[3-(6,8-difluoro-imidazo[1,2-

a]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-methanone

242

(6,6-dideuterio-1,4-oxazepan-4-yl)-[3-(1H-indol-3-yl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]methanone

243

[3-(1H-indol-3-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-c]pyridin-

6-yl]-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)methanone

244

3-[6-(Azepane-1-carbonyl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-3-yl]-8-methyl-imidazo[1,2-a]pyridine-6-

carboxylic acid amide

245

3-[6-(Azepane-1-carbonyl)-1-propyl-1H-pyrazolo[4,3-c]pyridin-3-

yl]-imidazo[1,2-a]pyridine-6-carboxylic acid amide

246

3-[6-(1,4-Oxazepane-4-carbonyl)-1-(2,2,2-trifluoro-ethyl)-1H-

pyrazolo[4,3-c]pyridin-3-yl]-imidazo[1,2-a]pyridine-6-carboxylic

acid amide

247

3-[6-(8-Oxa-3-aza-bicyclo[3.2.1]octane-3-carbonyl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-3-yl]-imidazo[1,2-

a]pyridine-6-carboxylic acid amide

248

Azepan-1-yl-[3-pyrazolo[1,5-a]pyrazin-3-yl-1-(2,2,2-trifluoro-

ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

249

1,4-Oxazepan-4-yl-[3-pyrazolo[1,5-a]pyrazin-3-yl-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

250

(1-Methanesulfonylmethyl-3-pyrazolo[1,5-a]pyrazin-3-yl-1H-

pyrazolo[4,3-c]pyridin-6-yl)-(1,4-oxazepan-4-yl)-methanone

251

[3-(benzimidazol-1-yl)-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(1,4-oxazepan-4-yl)methanone

252

[3-(6-fluorobenzimidazol-1-yl)-1-(2,2,2-

trifluoroethyl)pyrazolo[4,3-c]pyridin-6-yl]-(1,4-oxazepan-4-

yl)methanone

253

[3-furo[3,2-b]pyridin-3-yl-1-(2,2,2-trifluoroethyl)pyrazolo[4,3-

c]pyridin-6-yl]-(1,4-oxazepan-4-yl)methanone

254

[1,4]Oxazepan-4-yl-[3-(1H-pyrrolo[3,2-b]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

255

[1,4]Oxazepan-4-yl-[3-(1H-pyrrolo[2,3-c]pyridin-3-yl)-1-(2,2,2-

trifluoro-ethyl)-1H-pyrazolo[4,3-c]pyridin-6-yl]-methanone

256

(8-Oxa-3-aza-bicyclo[3.2.1]oct-3-yl)-[3-(1H-pyrrolo[3,2-

c]pyridin-3-yl)-1-(2,2,2-trifluoro-ethyl)-1H-pyrazolo[4,3-

c]pyridin-6-yl]-methanone

and pharmaceutically acceptable salts, solvates and prodrugs of any one of the afore-mentioned compounds.

12 . The compound of claim 1 for use as a medicament.

13 . A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.

14 . The compound of claim 1 for use in therapy as a dual adenosine A 2A and A 2B receptor antagonist.

15 . The compound of claim 1 for use in the treatment or prevention of a hyperproliferative disease or disorder or an infectious disease or disorder.

16 . A method of treating or preventing a hyperproliferative disease or disorder the method comprising administering the compound of claim 1 to a subject in need thereof.

17 . A method of treating or preventing a hyperproliferative disease or disorder or an infectious disease or disorder, the method comprising administering the compound of claim 1 to a subject in need thereof.

18 . The method according to claim 16 , wherein said hyperproliferative disease or disorder is cancer.

19 . The method according to claim 18 , wherein the cancer is selected from the group consisting of acute granulocytic leukemia, acute lymphocytic leukemia, acute myeloid leukemia, adrenal cortex cancer, bladder cancer, brain cancer, breast cancer, cervical cancer, cervical hyperplasia, cervical cancer, chorio cancer, chronic granulocytic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, colon cancer, endometrial cancer, esophageal cancer, essential thrombocytosis, genitourinary carcinoma, glioma, glioblastoma, hairy cell leukemia, head and neck carcinoma, Hodgkin's disease, Kaposi's sarcoma, lung carcinoma, lymphoma, malignant carcinoid carcinoma, malignant hypercalcemia, malignant melanoma, malignant pancreatic insulinoma, medullary thyroid carcinoma, melanoma, multiple myeloma, mycosis fungoides, neuroblastoma, non-Hodgkin's lymphoma, non-small cell lung cancer, osteogenic sarcoma, ovarian carcinoma, pancreatic carcinoma, polycythemia vera, primary brain carcinoma, primary macroglobulinemia, prostatic cancer, renal cell cancer, rhabdomyosarcoma, skin cancer, small-cell lung cancer, soft-tissue sarcoma, squamous cell cancer, stomach cancer, testicular cancer, thyroid cancer and Wilms' tumor.

20 . The method according to claim 16 , wherein said hyperproliferative disease or disorder is selected from the group consisting of age-related macular degeneration, Crohn's disease, cirrhosis, a chronic inflammatory-related disorder, proliferative diabetic retinopathy, proliferative vitreoretinopathy, retinopathy of prematurity, granulomatosis, immune hyperproliferation associated with organ or tissue transplantation, and an immunoproliferative disease/disorder.

21 . The method according to claim 20 , wherein the hyperproliferative disease or disorder is an immunoproliferative disease or disorder, and wherein the immunoproliferative disease or disorder is selected from the group consisting of inflammatory bowel disease, psoriasis, rheumatoid arthritis, systemic lupus erythematosus (SLE), vascular hyperproliferation secondary to retinal hypoxia, and vasculitis.

22 . The method according to claim 17 , wherein the disease or disorder to be treated or prevented is an infectious disease or disorder, and wherein said infectious disease or disorder is selected from the group consisting of:

(a) virally induced infectious diseases which are caused by retroviruses, hepadnaviruses, herpesviruses, flaviviridae and/or adenoviruses, wherein the retroviruses are selected from lend viruses or oncoretroviruses, wherein the lentivirus is selected from the group consisting of HIV-1, HIV-2, FIV, BIV, SIVs, SHIV, CAEV, VMV and EIAV, wherein the oncoretrovirus is selected from the group consisting of HTLV-I, HTLV-II and BLV, wherein the hepadnavirus is selected from the group consisting of HBV, GSHV and WHV, wherein the herpesvirus is selected from the group consisting of HSV I, HSV II, EBV, VZV, HCMV and HHV 8, and wherein the flaviviridae are selected from the group consisting of HCV, West nile and Yellow Fever;

(b) bacterial infectious diseases which are caused by Gram-positive bacteria, wherein the Gram-positive bacteria are selected from the group consisting of methicillin-susceptible and methicillin-resistant staphylococci (including Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus saprophyticus , and coagulase-negative staphylococci), glycopeptides-intermediate susceptible Staphylococcus aureus (GISA), penicillin-susceptible and penicillin-resistant streptococci (including Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus agalactiae, Streptococcus avium, Streptococcus bovis, Streptococcus lactis, Streptococcus sanguis and Streptococci Group C (GCS), Streptococci Group G (GGS) and viridans streptococci), enterococci (including vancomycinsusceptible and vancomycin-resistant strains such as Enterococcus faecalis and Enterococcus faecium ), Clostridium difficile, Listeria monocytogenes, Corynebacterium jeikeium, Chlamydia spp (including C. pneumoniae ) and Mycobacterium tuberculosis;

(c) bacterial infectious diseases which are caused by Gram-negative bacteria, wherein the Gram-negative bacteria are selected from the group consisting of the genus Enterobacteriaceae, including Escherichia spp. (including Escherichia coli ), Klebsiella spp., Enterobacter spp., Citrobacter spp., Serratia spp., Proteus spp., Providencia spp., Salmonella spp., Shigella spp., the genus Pseudomonas (including P. aeruginosa ), Moraxella spp. (including M. catarrhalis ), Haemophilus spp. and Neisseria spp.; and

(d) infectious diseases induced by intracellular active parasites selected from the group consisting of the phylum Apicomplexa, Sarcomastigophora (including Trypanosoma, Plasmodia, Leishmania, Babesia or Theileria ), Cryptosporidia, Sacrocystida, Amoebia, Coccidia and Trichomonadia.

23 . The method according to claim 17 , wherein said compound is administered in combination with one or more further therapeutic agents.

24 . The method according to claim 17 , wherein the subject to be treated is a human.

25 . A set or kit comprising separate packs of:

(a) a compound as defined in claim 1 ; and

(b) a further therapeutic agent.

26 . In vitro use of a compound as defined in claim 1 as a dual adenosine A 2A and A 2B receptor antagonist.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2025
From: MERCK PATENT GMBH; MERCK HEALTHCARE KGAA
To: DOMAIN THERAPEUTICS
Reel/Frame 072033/0504 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2021
From: BLAYO, ANNE-LAURE; MANTEAU, BAPTISTE; DORANGE, ISMET; MAYER, STANISLAS; SCHANN, STEPHAN; CATELAIN, THOMAS
To: DOMAIN THERAPEUTICS SA
Reel/Frame 056128/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2021
From: DOMAIN THERAPEUTICS SA
To: MERCK HEALTHCARE KGAA
Reel/Frame 056129/0039 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2021
From: MERCK HEALTHCARE KGAA
To: MERCK PATENT GMBH
Reel/Frame 056129/0183 →